FEATURES

• Can be perform in outpatient conditions.
• Non-tumescent procedure. Short procedure time.
• Closure of the target vessel can be obtained in seconds.
• No burn marks, skin pigmentation or lessions, numbness.
• No need to use compression stocking after the procedure.
• Patients can return daily routines and activities immediately.
• VenaBLOCK MicroCatheter
• Braided PTFE Catheter
• Laser guided
• High echogenity and better visibility under USG
• Excellent pushability
• Marked on every 2 cm

The VenaBLOCK closure system is indicated for use in closure of saphenous vein (vena saphena magna, valve saphenous parva) or perforator veins in endovenous treatment of incompetent varicose veins.VenaBlock is a n-BCA-polymer structure of which was changed by adding a monomer synthesized by the producing company. It is a ready for use, blue colored, transparent liquid. Product show polymerization effect with embolization. When contacted with living tissue and in humid environments, it very fast becomes polymerized by forming a thin, flexible membrane with high tension resistance that ensure sticking firmly to the tissues. The subject matter membrane ensures natural fit with the structure of the tissues, it is watertight, does not effects the structures of the blood and organic liquids. This formed membrane, since the polymerization of the product does not cause occurrence of glassy components, it can easily be perforated with surgical needle after it is hardened. The polymerization time changes according to the type of tissue polymer contacted, characteristics of the liquid found, and amount of the product used. When it is applied in the right conditions, VenaBlock starts polymerization after 1-2 seconds and finish the polymerization process in about 5 seconds.

POTENTIAL ADVERSE EFFECTS

Below is a list of the potential adverse effects (e.g., complications) associated with the use of the VenaBlock system. The adverse events associated with the device are similar to those with traditional endovenous thermal ablation procedures.

• Allergic reactions to cyanoacrylates, such as hives, asthma, hay fever and anaphylactic shock
• Arteriovenous fistula
• Bleeding from the site of access
• Deep vein thrombosis (DVT)
• Edema in the treated leg
• Embolization, including pulmonary embolism (PE)
• Hematoma
• Hyperpigmentation
• Infection at the access site
• Non-specific mild inflammation of the cutaneous and subcutaneous tissue
• Pain
• Paresthesia
• Phlebitis
• Superficial thrombophlebitis
• Urticaria or ulceration may occur at the site of injection
• Vascular rupture and perforation
• Visible scarring